
Results
120
Most Searched for companies on Simply Wall St (as in this app) ... to be used for "Trending" stocks
120 companies
Zhejiang Taimei Medical Technology
Market Cap: HK$2.1b
Zhejiang Taimei Medical Technology Co., Ltd.
2576
HK$3.73
7D
-3.4%
1Y
-25.7%
China Regenerative Medicine International
Market Cap: HK$155.2m
An investment holding company, provides healthcare products and services in Hong Kong and the People’s Republic of China.
8158
HK$0.51
7D
17.2%
1Y
45.7%
Pak Fah Yeow International
Market Cap: HK$757.3m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.49
7D
1.6%
1Y
2.0%
Jacobson Pharma
Market Cap: HK$2.5b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.24
7D
-3.9%
1Y
22.8%
Mirxes Holding
Market Cap: HK$13.2b
A micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China.
2629
HK$47.12
7D
-7.6%
1Y
n/a
TYK Medicines
Market Cap: HK$5.2b
A clinical-stage biopharmaceutical company, research, development and commercialization of pharmaceutical products.
2410
HK$13.32
7D
1.4%
1Y
-75.6%
CANbridge Pharmaceuticals
Market Cap: HK$1.0b
A biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare diseases and oncology indications worldwide.
1228
HK$1.92
7D
-12.3%
1Y
1,206.1%
WuXi XDC Cayman
Market Cap: HK$85.3b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$70.00
7D
5.6%
1Y
118.8%
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
Market Cap: HK$7.4b
Engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China.
1349
HK$2.82
7D
-2.4%
1Y
13.3%
Shandong Boan Biotechnology
Market Cap: HK$5.4b
A biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China.
6955
HK$8.98
7D
0.3%
1Y
2.3%
Cutia Therapeutics
Market Cap: HK$1.9b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$5.19
7D
-11.9%
1Y
-24.0%
AIM Vaccine
Market Cap: HK$4.2b
Engages in the research and development, manufacture, and sale of vaccine products for human use in the People’s Republic of China.
6660
HK$3.44
7D
-2.0%
1Y
-46.1%